On January 24, 2024, Establishment Labs Holdings Inc. closed the transaction. The company has now issued 1,101,565 common shares at a price of $25 per share for the gross proceeds of $27,539,125 and 898,435 warrants at a price of $24.999 per warrant for the gross proceeds of $22,459,976.565; for total gross proceeds of $49,999,101.565 pursuant to Regulation D. The transaction included participation from 10 investors.
Establishment Labs Holdings Inc.
Equities
ESTA
VGG312491084
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
57.28 USD | -1.16% | +2.48% | +121.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+121.51% | 1.59B | |
-5.52% | 182B | |
+4.23% | 114B | |
-3.25% | 68.38B | |
+5.39% | 52.46B | |
+8.06% | 44.25B | |
+7.52% | 43.55B | |
+24.66% | 32.69B | |
+17.85% | 26.73B | |
+0.80% | 25.79B |
- Stock Market
- Equities
- ESTA Stock
- News Establishment Labs Holdings Inc.
- Establishment Labs Holdings Inc. announced that it has received $49.999102 million in funding